Unicycive Therapeutics, Inc.
UNCY
$6.93
-$0.19-2.67%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -26.56M | -33.41M | -31.50M | -15.20M | -36.73M |
| Total Depreciation and Amortization | 572.00K | 555.00K | 530.00K | 279.00K | 428.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 620.00K | 5.22M | 4.40M | -11.96M | 8.15M |
| Change in Net Operating Assets | -5.95M | -2.19M | -6.56M | -4.14M | -427.00K |
| Cash from Operations | -31.32M | -29.83M | -33.12M | -31.02M | -28.58M |
| Capital Expenditure | -24.00K | -46.00K | -68.00K | -82.00K | -72.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -12.07M | -- | -- | -- | -- |
| Cash from Investing | -12.10M | -46.00K | -68.00K | -82.00K | -72.00K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 48.08M | 41.95M | 14.80M | 3.47M | 683.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | 0.00 | 0.00 | 0.00 | 50.00M |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | 0.00 | 0.00 | -1.10M | -1.10M |
| Other Financing Activities | -1.61M | -1.72M | -1.07M | -435.00K | -4.50M |
| Cash from Financing | 46.47M | 40.23M | 13.74M | 1.94M | 45.09M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 3.06M | 10.35M | -19.45M | -29.16M | 16.44M |